Evidence map›Paper›PMID 39219493›Full record

ArticleMolecular and cellular biology2024

Hiroyuki Takatsu, Narumi Nishimura, Yusuke Kosugi, Haruo Ogawa, Kazuhisa Nakayama, Estelle Colin, Konrad Platzer, Rami Abou Jamra, Silke Redler, Clément Prouteau and 2 more

Abstract read
In one paragraph

Article in Molecular and cellular biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hiroyuki TakatsuDepartment of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.
Narumi NishimuraDepartment of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.
Yusuke KosugiDepartment of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.
Haruo OgawaDepartment of Structural Biology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.
Kazuhisa NakayamaDepartment of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.
Estelle ColinDepartment of Medical Genetics, Angers University Hospital, Angers, France.
Konrad PlatzerInstitute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
Rami Abou JamraInstitute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
Silke RedlerInstitute of Human Genetics, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Clément ProuteauDepartment of Medical Genetics, Angers University Hospital, Angers, France.
Alban ZieglerDepartment of Medical Genetics, Angers University Hospital, Angers, France.
Hye-Won ShinDepartment of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.ORCID 0000-0002-9138-9554

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

P4-ATPases comprise a family of lipid flippases that translocate lipids from the exoplasmic (or luminal) to the cytoplasmic leaflet of biological membranes. Of the 14 known human P4-ATPases, ATP8B2 is a phosphatidylcholine flippase at the plasma membrane, but its physiological function is not well understood. Although ATP8B2 could interact with both CDC50A and CDC50B, it required only the CDC50A interaction for its exit from the endoplasmic reticulum and subsequent transport to the plasma membrane. Three de novo monoallelic missense variations of ATP8B2 were found in patients with intellectual disability. None of these variations affected the interaction of ATP8B2 with CDC50A or its localization to the plasma membrane. However, variations of either of two amino acid residues, which are conserved in all P4-ATPases, significantly reduced the phosphatidylcholine flippase activity of ATP8B2. Furthermore, mutations in the corresponding residues of ATP8B1 and ATP11C were found to decrease their flippase activities toward phosphatidylcholine and phosphatidylserine, respectively. These results indicate that the conserved amino acid residues are crucial for the enzymatic activities of the P4-ATPases.

Indexed as

Adenosine TriphosphatasesMutation, MissensePhosphatidylcholinesAmino Acid SequenceCell MembraneEndoplasmic ReticulumHEK293 CellsHumansIntellectual DisabilityMembrane ProteinsMembrane Transport ProteinsPhosphatidylserinesPhospholipid Transfer ProteinsAdenosine TriphosphatasesATP11C protein, humanATP8A2 protein, humanATP8B1 protein, humanMembrane ProteinsMembrane Transport ProteinsPhosphatidylcholinesPhosphatidylserinesPhospholipid Transfer ProteinsTMEM30a protein, humanflippaseLipid bilayerP-type ATPase

Identifiers

PMID39219493
PMCPMC11529410

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.